Edition:
India

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

111.00PLN
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
111.00zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,602
52-wk High
139.00zł
52-wk Low
88.21zł

Chart for

About

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in... (more)

Overall

Beta: 0.80
Market Cap(Mil.): zł1,233.10
Shares Outstanding(Mil.): 11.80
Dividend: --
Yield (%): --

Financials

BRIEF-EBRD Buys 5.72% Stake Of Mabion

* EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT (EBRD) BUYS ABOUT 5.72% STAKE IN CO IN SHARES ACQUISITION TRANSACTION

27 Mar 2018

BRIEF-EBRD, PFR Life Science Among Investors Of Mabion

* AMONG INVESTORS WHO ARE TO INVEST IN CO ARE EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT (EBRD) AND PFR LIFE SCIENCE SP. Z O.O.

23 Mar 2018

BRIEF-Mabion Confirms Final Results Of Clinical Trial Of MabionCD20 RZS

* CONFIRMS THAT POSITIVE PRELIMINARY RESULTS OF CLINICAL TRIAL OF MABIONCD20 RZS CHANGE ITS STATUS TO FINAL

23 Mar 2018

BRIEF-Mabion Obtains 174.8 Mln Zloty Financing Through Loan From Shareholder

* OBTAINS 174.8 MILLION ZLOTY FINANCING THROUGH LOAN FROM SHAREHOLDER

23 Mar 2018

Earnings vs. Estimates